WEBULL
News
HLUBF
5.37
NaN%
--
Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid
Seeking Alpha · 11/19/2025 12:00
Avadel Shareholders Wake Up To A Competing Bid For Their Shares
Seeking Alpha · 11/14/2025 16:50
Avadel climbs as Lundbeck outbids Alkermes in latest bidding war
Seeking Alpha · 11/14/2025 11:57
Weekly Report: what happened at HLUBF last week (0908-0912)?
Weekly Report · 09/15/2025 12:12
Weekly Report: what happened at HLUBF last week (0901-0905)?
Weekly Report · 09/08/2025 12:15
Weekly Report: what happened at HLUBF last week (0825-0829)?
Weekly Report · 09/01/2025 12:07
Weekly Report: what happened at HLUBF last week (0818-0822)?
Weekly Report · 08/25/2025 12:24
Weekly Report: what happened at HLUBF last week (0811-0815)?
Weekly Report · 08/18/2025 12:12
Weekly Report: what happened at HLUBF last week (0804-0808)?
Weekly Report · 08/11/2025 12:23
Weekly Report: what happened at HLUBF last week (0728-0801)?
Weekly Report · 08/04/2025 12:26
Weekly Report: what happened at HLUBF last week (0721-0725)?
Weekly Report · 07/28/2025 12:27
Weekly Report: what happened at HLUBF last week (0714-0718)?
Weekly Report · 07/21/2025 12:13
Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting
Seeking Alpha · 07/16/2025 18:25
Weekly Report: what happened at HLUBF last week (0707-0711)?
Weekly Report · 07/14/2025 12:27
Weekly Report: what happened at HLUBF last week (0630-0704)?
Weekly Report · 07/07/2025 12:13
Weekly Report: what happened at HLUBF last week (0623-0627)?
Weekly Report · 06/30/2025 12:23
Weekly Report: what happened at HLUBF last week (0616-0620)?
Weekly Report · 06/23/2025 12:12
Weekly Report: what happened at HLUBF last week (0609-0613)?
Weekly Report · 06/16/2025 12:22
Weekly Report: what happened at HLUBF last week (0602-0606)?
Weekly Report · 06/09/2025 12:24
Weekly Report: what happened at HLUBF last week (0526-0530)?
Weekly Report · 06/02/2025 12:37
More
Webull provides a variety of real-time HLUBF stock news. You can receive the latest news about H.Lundbeck through multiple platforms. This information may help you make smarter investment decisions.
About HLUBF
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.